Christopher B. Begley plans to retire from his role as chief executive officer of Hospira Inc. Mr. Begley will remain until his successor is named. He will continue to serve as executive chairman of the board. Also, Terrence C. Kearney, chief operating officer, will retire by the end of 2010. During Mr. Begley’s tenure, he oversaw Hospira’s 2004 spin-off from Abbott Laboratories and doubled the company’s geographic footprint and revenue outside the U.S. He remarked, “Over the last...